摘要
目的:观察生物反馈治疗失眠症的临床疗效。方法:选择新疆昌吉回族自治州人民医院门诊及住院失眠症患者30例作为研究对象,随机分为观察组和对照组,分别给予生物反馈治疗和阿普唑仑治疗,疗程均为3周,分别于治疗前后观察匹兹堡睡眠质量指数量表(PSQI)情况。结果:2组患者治疗后临床疗效比较,差异无统计学意义(P>0.05);观察组治疗前后PSQI评分比较差异有统计学意义(P<0.05);对照组治疗前后PSQI评分比较差异有统计学意义(P<0.05),而2组治疗后PSQI评分比较差异无统计学意义(P>0.05)。结论:生物反馈治疗失眠症与阿普唑仑片的疗效基本一致,但生物反馈治疗失眠症不良反应少,无不良反应,无成瘾性,值得推广。
Objective:To observe the clinical effect of biofeedback in the treatment of insomnia.Methods:A total of 30 patients with insomnia outpatient and inpatient were randomly divided into observation group and control group.The patients in the two groups were given biofeedback treatment and alprazolam treatment for 3 weeks,and were evaluated with the Pittsburgh sleep quality index(PSQI)scale before and after treatment.Results:There was no significant difference in clinical efficacy between the two groups after treatment(P>0.05).There were a statistical differences before and after treatment in 2 groups(P<0.05).While there was no statistically significant difference between the observation group and the control group after treatment(P<0.05).Conclusion:The effect of biofeedback therapy on insomnia is basically the same as that of alprazolam tablets,and biofeedback therapy on insomnia with few adverse reactions,no side effects,no addiction,and is worth popularizing.
作者
魏小东
马尔江
赵琦英
王敏
赵芬
姚晶
WEI Xiaodong;MA Erjiang;ZHAO Qiying;WANG Min;ZHAO Fen;YAO Jing(People′s Hospital of Xinjiang Changji Hui Autonomous Prefecture,Changji 831100,China)
出处
《世界睡眠医学杂志》
2021年第9期1652-1653,共2页
World Journal of Sleep Medicine